IMRX Klasse A Immuneering Corporation - Class A Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 5, 2026
$4,07
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$3,8652-Wochen-Tief
$8,4852-Wochen-Hoch
P/E
-5.2
EPS
$-1.27
Umsatz
$0
Ihre Abzeichen
52W-Spanne
$4–$8
Analystenbewertung
BUY
Kursziel
$17
P/E
-5.2
ROE
-45.3%
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
IMRX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$4.07
P/E
-5.2
EPS
$-1.27
Umsatz
$0
ROE
-45.3%
52W-Spanne
$4–$8
IMRX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$02020-12-31 → 2023-12-31
EPS$-1.272020-12-31 → 2025-12-31
Freier Cashflow$-45M2021-12-31 → 2025-12-31
Nettogewinnmarge·2021-12-31 → 2022-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | IMRX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -5.25-Jahres-Durchschnitt ≈-3.9 | ≈-3.9 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | IMRX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| ROA | -39.4%5-Jahres-Durchschnitt ≈-46.6% | ≈-46.6% | -34.5% | Schwach | |
| ROE | -45.3%5-Jahres-Durchschnitt ≈-57.7% | ≈-57.7% | -38.3% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | IMRX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 19.55-Jahres-Durchschnitt ≈14.9 | ≈14.9 | 17.6 | Im Einklang | |
| Quick Ratio | 12.85-Jahres-Durchschnitt ≈13.0 | ≈13.0 | 11.6 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | IMRX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$0.00 | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
15.9%
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 12, 2026 | $-0.27 | $-0.27 | 1.2% |
| 31. März 2026 | Mai 15, 2026 | $-0.21 | $-0.26 | 18.3% |
| 31. Dezember 2025 | $-0.18 | $-0.32 | 43.7% | |
| 30. September 2025 | $-0.38 | $-0.40 | 5.0% | |
| 30. Juni 2025 | $-0.40 | $-0.42 | 5.5% | |
| 31. März 2025 | $-0.42 | $-0.54 | 21.8% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $317.0K | $2M | $2M | |
| Cost of Revenue | · | · | $0 | $158.1K | $1M | $1M | |
| Gross Profit | · | · | $0 | $158.8K | $926.9K | $1M | |
| R&D Expense | $42M | $48M | $42M | $36M | $27M | $15M | |
| SG&A Expense | $17M | $16M | $17M | $16M | $8M | $3M | |
| Operating Expenses | $59M | $64M | $58M | $52M | $35M | $18M | |
| Operating Income | $-59M | $-64M | $-58M | $-52M | $-34M | $-17M | |
| Interest Income | $3M | $3M | $4M | $1M | $169.9K | $42.7K | |
| Other Non-op | $311.7K | $441.5K | $1M | $216.8K | $-127.1K | · | |
| Pretax Income | · | · | · | $-51M | $-34M | $-17M | |
| Income Tax | $0 | · | · | · | $-307.5K | · | |
| Net Income | $-56M | $-61M | $-53M | $-51M | $-34M | $-17M | |
| EPS (Basic) | $-1.27 | $-2.04 | $-1.88 | $-1.91 | $-2.46 | $-3.44 | |
| EPS (Diluted) | $-1.27 | $-2.04 | $-1.88 | $-1.91 | $-2.46 | $-3.44 | |
| Shares (Basic) | 44,011,830 | 29,981,565 | 28,416,558 | 26,386,864 | 13,612,677 | 4,950,129 | |
| Shares (Diluted) | 44,011,830 | 29,981,565 | 28,416,558 | 26,386,864 | 13,612,677 | 4,950,129 | |
| EBITDA | $-59M | $-64M | $-58M | $-52M | $-34M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $129M | $36M | $59M | $73M | $75M | $37M | |
| Short-term Investments | · | · | · | $33M | $74M | · | |
| Receivables | · | · | $0 | $12.4K | $246.0K | $500.1K | |
| Prepaid Expense | $3M | $3M | $3M | $3M | $3M | $141.0K | |
| Current Assets | $176M | $40M | $89M | $109M | $152M | $38M | |
| PP&E (Net) | $938.5K | $1M | $1M | $1M | $807.2K | $64.4K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $981.4K | $193.1K | |
| Accum. Depreciation | $1M | $1M | $728.3K | $418.3K | $174.2K | $128.8K | |
| Goodwill | $7M | $7M | $7M | $7M | $7M | · | |
| Intangibles | $321.1K | $350.4K | $379.7K | $408.9K | $439.0K | · | |
| Other Non-current Assets | $283.6K | $1M | $1M | $743.7K | $102.1K | $14.3K | |
| Total Assets | $232M | $53M | $103M | $122M | $167M | $38M | |
| Accounts Payable | $2M | $2M | $2M | $3M | $1M | $1M | |
| Accrued Liabilities | $8M | $5M | $5M | $5M | $4M | $699.0K | |
| Current Liabilities | $10M | $8M | $8M | $8M | $6M | $2M | |
| Capital Leases | $3M | $4M | $4M | $4M | $5M | $544.8K | |
| Total Liabilities | $14M | $11M | $12M | $13M | $11M | $3M | |
| Paid-in Capital | $499M | $266M | $254M | $220M | $215M | $3M | |
| Retained Earnings | $-280M | $-224M | $-163M | $-110M | $-59M | $-26M | |
| AOCI | $81.3K | $0 | $-778 | $-30.1K | $-49.0K | · | |
| Stockholders' Equity | $218M | $41M | $91M | $110M | $156M | $-22M | |
| Liabilities + Equity | $232M | $53M | $103M | $122M | $167M | $38M |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $324.5K | $355.8K | $322.8K | · | · | · | |
| Stock-based Comp | $6M | $7M | $6M | $4M | $2M | $1M | |
| Deferred Tax | · | · | · | · | $-307.5K | · | |
| Amort. of Intangibles | $29.3K | $29.3K | $29.3K | $30.1K | · | · | |
| Other Non-cash | $4M | $-820.1K | · | · | · | · | |
| Operating Cash Flow | $-45M | $-55M | $-49M | $-44M | $-31M | $-15M | |
| CapEx | $142.2K | $84.9K | $342.7K | $742.5K | $60.8K | $53.4K | |
| Investing Cash Flow | $-89M | $26M | $7M | $42M | $-76M | $-53.4K | |
| Stock Issued | · | · | $28M | $0 | $120M | · | |
| Net Stock Activity | · | · | $28M | · | $120M | · | |
| Financing Cash Flow | $227M | $5M | $28M | $19.0K | $144M | $38M | |
| Net Change in Cash | $93M | $-23M | $-13M | $-2M | $38M | $23M | |
| Free Cash Flow | $-45M | $-55M | $-49M | $-45M | $-31M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | 50.1% | 44.6% | · | |
| Operating Margin | · | · | · | -16325.8% | -1629.2% | · | |
| Net Margin | · | · | · | -15937.3% | -1612.3% | · | |
| Pretax Margin | · | · | · | -15937.3% | -1627.1% | · | |
| EBITDA Margin | · | · | · | -16325.8% | -1629.2% | · | |
| ROA | -39.4% | -78.6% | -47.5% | -34.9% | -32.7% | · | |
| ROE | -45.3% | -123.2% | -55.0% | -43.6% | -21.3% | · | |
| ROIC | · | · | · | · | -21.5% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 17.5 | 5.3 | 11.4 | 13.5 | 27.0 | · | |
| Quick Ratio | 12.8 | 4.8 | 7.6 | 13.1 | 26.5 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.0 | 0.0 | 0.0 | · | |
| Receivables Turnover | · | · | 0.0 | 2.5 | 5.6 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue / Share | · | · | $0.00 | $0.01 | $0.15 | · | |
| Cash Flow / Share | $-1.03 | $-1.83 | $-1.72 | $-1.67 | $-2.27 | · | |
| EPS (TTM) | $-1.27 | $-2.04 | $-1.88 | $-1.91 | $-2.46 | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | -84.8% | -10.0% | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $38.4K | $38.4K | $0 | $317.0K | $2M | · | |
| Net Income TTM | $-56M | $-61M | $-53M | $-51M | $-34M | · | |
| P/E | -5.2 | -1.1 | -3.9 | -2.5 | -6.6 | · | |
| Earnings Yield | -19.3% | -92.7% | -25.6% | -39.4% | -15.2% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $455 | $38.4K | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $19.3K | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $455 | $19.0K | |
| R&D Expense | $14M | $11M | $9M | $11M | $10M | $11M | $15M | $11M | $11M | $11M | $12M | $10M | $9M | $10M | $10M | $9M | |
| SG&A Expense | $5M | $5M | $4M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Operating Expenses | $19M | $15M | $14M | $15M | $15M | $15M | $19M | $15M | $15M | $15M | $16M | $14M | $14M | $15M | $14M | $13M | |
| Operating Income | $-19M | $-15M | $-14M | $-15M | $-15M | $-15M | $-19M | $-15M | $-15M | $-15M | $-16M | $-14M | $-14M | $-15M | $-14M | $-13M | |
| Interest Income | $1M | $1M | $2M | $415.8K | $324.0K | $438.5K | $415.2K | $547.1K | $826.1K | $804.9K | $754.1K | $855.5K | $1M | $831.3K | $516.2K | $223.0K | |
| Other Non-op | $647.2K | $513.7K | $311.7K | $0 | $0 | $0 | $91.4K | $129.3K | $7.7K | $213.0K | $464.4K | $475.6K | $150.2K | $244.1K | $223.3K | $120.8K | |
| Net Income | $-17M | $-13M | $-12M | $-15M | $-14M | $-15M | $-18M | $-15M | $-14M | $-14M | $-15M | $-13M | $-12M | $-14M | $-13M | $-13M | |
| EPS (Basic) | $-0.27 | $-0.21 | $-0.07 | $-0.38 | $-0.40 | $-0.42 | $-0.59 | $-0.49 | $-0.47 | $-0.49 | $-0.51 | $-0.43 | $-0.43 | $-0.51 | $-0.49 | $-0.49 | |
| EPS (Diluted) | $-0.27 | $-0.21 | $-0.07 | $-0.38 | $-0.40 | $-0.42 | $-0.59 | $-0.49 | $-0.47 | $-0.49 | $-0.51 | $-0.43 | $-0.43 | $-0.51 | $-0.49 | $-0.49 | |
| Shares (Basic) | 64,697,219 | 64,658,809 | · | 39,670,095 | 35,985,878 | 35,529,652 | · | 29,841,883 | 29,653,355 | 29,370,357 | · | 29,266,309 | 28,647,450 | 26,442,216 | · | 26,394,490 | |
| Shares (Diluted) | 64,697,219 | 64,658,809 | · | 39,670,095 | 35,985,878 | 35,529,652 | · | 29,841,883 | 29,653,355 | 29,370,357 | · | 29,266,309 | 28,647,450 | 26,442,216 | · | 26,394,490 | |
| EBITDA | $-19M | $-15M | · | $-15M | $-15M | $-15M | · | $-15M | $-15M | $-15M | · | $-14M | $-13M | $-15M | · | $-13M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $47M | $129M | $228M | $26M | $36M | $36M | $45M | $60M | $66M | $59M | $68M | $104M | $77M | $73M | $76M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $41M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $1.0K | $12.4K | $70.2K | |
| Prepaid Expense | $8M | $5M | $3M | $2M | $1M | $2M | $3M | $5M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Current Assets | $158M | $161M | $176M | $229M | $28M | $38M | $40M | $55M | $64M | $74M | $89M | $101M | $112M | $94M | $109M | $120M | |
| PP&E (Net) | $879.9K | $937.0K | $938.5K | $892.6K | $964.1K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $997.0K | $909.0K | $818.5K | $728.3K | $648.0K | $569.7K | $492.9K | $418.3K | $344.6K | |
| Goodwill | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | |
| Intangibles | $306.5K | $313.8K | $321.1K | $328.5K | $335.8K | $343.1K | $350.4K | $357.7K | $365.0K | $372.4K | $379.7K | $387.0K | $394.3K | $401.6K | $408.9K | $416.3K | |
| Other Non-current Assets | $278.1K | $278.1K | $283.6K | $631.3K | $841.7K | $810.9K | $1M | $1M | $1M | $1M | $1M | $743.7K | $743.7K | $743.7K | $743.7K | $737.3K | |
| Total Assets | $202M | $215M | $232M | $241M | $40M | $51M | $53M | $69M | $77M | $88M | $103M | $114M | $125M | $108M | $122M | $134M | |
| Accounts Payable | $3M | $1M | $2M | $2M | $2M | $1M | $2M | $2M | $3M | $2M | $2M | $2M | $3M | $3M | $3M | $2M | |
| Accrued Liabilities | $4M | $3M | $8M | $7M | $5M | $3M | $5M | $5M | $4M | $3M | $5M | $3M | $2M | $2M | $5M | $5M | |
| Current Liabilities | $8M | $5M | $10M | $10M | $7M | $5M | $8M | $7M | $7M | $5M | $8M | $6M | $5M | $6M | $8M | $7M | |
| Capital Leases | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | |
| Total Liabilities | $11M | $8M | $14M | $13M | $11M | $9M | $11M | $11M | $11M | $9M | $12M | $10M | $10M | $10M | $13M | $12M | |
| Paid-in Capital | $502M | $500M | $499M | $497M | $283M | $281M | $266M | $264M | $258M | $256M | $254M | $252M | $251M | $221M | $220M | $219M | |
| Retained Earnings | $-311M | $-294M | $-280M | $-269M | $-254M | $-239M | $-224M | $-206M | $-192M | $-178M | $-163M | $-148M | $-136M | $-123M | $-110M | $-97M | |
| AOCI | $-406.2K | $-241.0K | $81.3K | · | · | · | $0 | $7.8K | $0 | $-1.1K | $-778 | $5.6K | $-2.2K | $506 | $-30.1K | $-142.5K | |
| Stockholders' Equity | $191M | $207M | $218M | $228M | $29M | $42M | $41M | $58M | $66M | $79M | $91M | $104M | $115M | $98M | $110M | $122M | |
| Liabilities + Equity | $202M | $215M | $232M | $241M | $40M | $51M | $53M | $69M | $77M | $88M | $103M | $114M | $125M | $108M | $122M | $134M |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $84.5K | $81.4K | $75.9K | $78.8K | $84.5K | $85.3K | $86.1K | $88.9K | $90.5K | $90.2K | $89.8K | $78.3K | $78.2K | $76.5K | · | $68.1K | |
| Stock-based Comp | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | |
| Amort. of Intangibles | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | |
| Other Non-cash | · | $-7M | · | · | · | $-812.0K | · | · | · | $-3M | · | · | · | · | · | · | |
| Operating Cash Flow | $-17M | $-18M | $-10M | $-12M | $-9M | $-14M | $-15M | $-13M | $-12M | $-15M | $-12M | $-12M | $-11M | $-14M | $-12M | $-11M | |
| CapEx | $27.4K | $79.9K | $123.9K | $7.3K | $2.1K | $8.9K | $9.4K | $5.3K | $32.8K | $37.5K | $170.9K | $57.1K | $86.7K | $28.0K | $69.3K | $393.1K | |
| Investing Cash Flow | $10M | $-63M | $-89M | $-7.3K | $-2.1K | $-8.9K | $5M | $-5M | $5M | $21M | $3M | $-24M | $9M | $19M | $8M | $-880.1K | |
| Stock Issued | · | · | · | · | $0 | $14M | · | · | $0 | $0 | · | $0 | · | · | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | $14M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $24.6K | $180.8K | $-357.5K | $213M | $-62.0K | $14M | $-41.0K | $4M | $0 | $979.9K | $7.8K | $21.4K | $28M | $239.4K | $-184.7K | $-17.2K | |
| Net Change in Cash | $-6M | $-81M | $-99M | $201M | $-10M | $-279.0K | $-9M | $-15M | $-7M | $7M | $-9M | $-36M | $27M | $5M | $-4M | $-12M | |
| Free Cash Flow | · | $-19M | · | · | · | $-14M | · | · | · | $-16M | · | · | · | $-14M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 49.6% | |
| Operating Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -34362.0% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -33466.2% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -34362.0% | |
| ROA | -14.3% | -10.1% | · | -9.7% | -24.6% | -21.7% | · | -16.0% | -13.9% | -14.6% | · | -10.2% | -9.1% | -10.5% | · | -8.6% | |
| ROE | -15.7% | -10.8% | · | -10.5% | -30.3% | -25.0% | · | -18.1% | -15.5% | -16.2% | · | -11.2% | -9.8% | -11.2% | · | -9.2% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 19.5 | 32.4 | · | 24.0 | 3.7 | 7.5 | · | 8.0 | 9.4 | 14.4 | · | 17.9 | 20.4 | 17.1 | · | 16.5 | |
| Quick Ratio | 5.1 | 9.5 | · | 23.8 | 3.5 | 7.0 | · | 6.5 | 8.8 | 12.8 | · | 12.1 | 19.0 | 14.0 | · | 16.2 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.1 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | · | · | · | · | · | · | · | · | · | · | · | $0.00 | $0.00 | $0.00 | · | $0.00 | |
| Cash Flow / Share | · | $-0.29 | · | · | · | $-0.40 | · | · | · | $-0.53 | · | · | · | $-0.55 | · | · | |
| EPS (TTM) | $-0.93 | $-1.06 | · | $-1.79 | $-1.90 | $-1.97 | · | $-1.96 | $-1.90 | $-1.86 | · | $-1.86 | $-1.92 | $-1.93 | · | $-0.54 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $455 | $455 | · | $455 | $455 | $455 | · | $455 | $455 | $455 | · | $455 | $38.8K | $133.3K | · | $506.1K | |
| Net Income TTM | $-57M | $-54M | · | $-62M | $-62M | $-62M | · | $-58M | $-56M | $-54M | · | $-52M | $-52M | $-51M | · | $-48M | |
| P/E | -5.4 | -5.0 | · | -3.9 | -1.8 | -0.8 | · | -1.3 | -0.7 | -1.6 | · | -4.1 | -5.3 | -5.0 | · | -26.5 | |
| Earnings Yield | -18.6% | -20.1% | · | -25.6% | -56.4% | -129.6% | · | -78.7% | -148.4% | -64.4% | · | -24.2% | -18.9% | -19.9% | · | -3.8% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | · | · | $0 | $317.0K | $2M |
| Bruttogewinnmarge % | · | · | · | 50.1% | 44.6% |
| Betriebsgewinnmarge % | · | · | · | -16325.8% | -1629.2% |
| Nettoergebnis | $-56M | $-61M | $-53M | $-51M | $-34M |
| Verwässerte EPS | $-1.27 | $-2.04 | $-1.88 | $-1.91 | $-2.46 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 17.5 | 5.3 | 11.4 | 13.5 | 27.0 |
| Quick Ratio | 12.8 | 4.8 | 7.6 | 13.1 | 26.5 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-45M | $-55M | $-49M | $-45M | $-31M |
Institutionelle Eigentümer (13F) 121 Einreicher · $183.1M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
121
Gehaltener Wert
$183.1M
Neue Positionen
37
Geschlossene Positionen
19
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 37 (+8 vs. Vorquartal) | 19 (+2 vs. Vorquartal) | 39 (+9 vs. Vorquartal) | 23 (-2 vs. Vorquartal) | +5.6M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $48.426.004 | 9.704.610 | 26,45% | Aktien |
| BlackRock, Inc. | $21.826.360 | 4.374.020 | 11,92% | Aktien |
| VANGUARD GROUP INC | $16.899.368 | 2.568.293 | 9,23% | Aktien |
| Sanofi | $13.515.709 | 2.708.559 | 7,38% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $11.409.306 | 2.286.434 | 6,23% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $6.841.807 | 1.370.750 | 3,74% | Aktien |
| STATE STREET CORP | $4.999.955 | 1.001.995 | 2,73% | Aktien |
| DCF Advisers, LLC | $3.942.100 | 790.000 | 2,15% | Aktien |
| MARSHALL WACE, LLP | $3.652.164 | 731.897 | 2,00% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $3.000.262 | 601.255 | 1,64% | Aktien |
| ALETHEA CAPITAL MANAGEMENT, LLC | $2.359.946 | 472.935 | 1,29% | Aktien |
| Summit Financial, LLC | $2.256.797 | 452.264 | 1,23% | Aktien |
| UBS Group AG | $2.239.796 | 448.857 | 1,22% | Aktien |
| Nuveen, LLC | $2.187.427 | 438.362 | 1,19% | Aktien |
| NORTHERN TRUST CORP | $2.180.590 | 436.992 | 1,19% | Aktien |
| LEVIN CAPITAL STRATEGIES, L.P. | $2.065.860 | 414.000 | 1,13% | Aktien |
| CITADEL ADVISORS LLC | $1.928.191 | 386.411 | 1,05% | Aktien |
| SOUTHPORT MANAGEMENT, L.L.C. | $1.825.957 | 277.501 | 1,00% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $1.800.212 | 360.764 | 0,98% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.791.834 | 359.085 | 0,98% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $1.648.706 | 330.402 | 0,90% | Aktien |
| Burkehill Global Management, LP | $1.497.000 | 300.000 | 0,82% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $1.439.216 | 288.420 | 0,79% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.409.675 | 282.500 | 0,77% | Kaufoption |
| MORGAN STANLEY | $1.130.190 | 226.491 | 0,62% | Aktien |
| Occam Crest Management LP | $1.129.309 | 278.498 | 0,62% | Aktien |
| D. E. Shaw & Co., Inc. | $1.016.278 | 203.663 | 0,56% | Aktien |
| JANE STREET GROUP, LLC | $915.665 | 183.500 | 0,50% | Kaufoption |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $837.826 | 167.901 | 0,46% | Aktien |
| Permanent Capital Management, LP | $748.500 | 150.000 | 0,41% | Aktien |
| PVG ASSET MANAGEMENT CORP | $730.790 | 146.451 | 0,40% | Aktien |
| HighTower Advisors, LLC | $715.995 | 143.486 | 0,39% | Aktien |
| Bank of New York Mellon Corp | $658.699 | 132.004 | 0,36% | Aktien |
| Kingsview Wealth Management, LLC | $613.770 | 123.000 | 0,34% | Aktien |
| BANK OF AMERICA CORP /DE/ | $578.066 | 115.845 | 0,32% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $544.409 | 109.100 | 0,30% | Verkaufsoption |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $539.664 | 108.149 | 0,29% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $527.987 | 105.809 | 0,29% | Aktien |
| GOLDMAN SACHS GROUP INC | $480.138 | 96.220 | 0,26% | Aktien |
| Fisher Asset Management, LLC | $440.781 | 88.333 | 0,24% | Aktien |
| Corient Private Wealth LP | $384.679 | 77.090 | 0,21% | Aktien |
| CITADEL ADVISORS LLC | $366.266 | 73.400 | 0,20% | Kaufoption |
| AMERIPRISE FINANCIAL INC | $356.555 | 71.454 | 0,19% | Aktien |
| CIBC Private Wealth Group LLC | $350.357 | 50.051 | 0,19% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $344.574 | 69.053 | 0,19% | Aktien |
| RHUMBLINE ADVISERS | $328.903 | 65.914 | 0,18% | Aktien |
| ALPS ADVISORS INC | $327.633 | 65.658 | 0,18% | Aktien |
| TD Asset Management Inc | $325.328 | 65.196 | 0,18% | Aktien |
| XTX Topco Ltd | $321.331 | 64.395 | 0,18% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $310.084 | 62.141 | 0,17% | Aktien |
Unternehmensinsider 16 Insider · 10 Führungskräfte · 7 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Benjamin J. Zeskind | PRESIDENT AND CEO | 23. Juni 2026 P | 2.315.252 | 1 | 0 | $10.944 |
| Andrew Gengos | Chief Financial Officer | 16. Juli 2026 A | · | 0 | 0 | $0 |
| Biren Amin | CFO, TREASURER | 12. Mai 2022 P | 7.898 | 0 | 0 | $0 |
| Brett Matthew Hall | CHIEF SCIENTIFIC OFFICER | 15. Juni 2026 P | 382.531 | 2 | 0 | $35.547 |
| Leah R Neufeld | CHIEF PEOPLE OFFICER | 13. März 2026 A | 29.598 | 1 | 0 | $10.898 |
| Harold Eugene Brakewood | Chief Business Officer | 3. Februar 2026 A | 11.050 | 1 | 0 | $24.990 |
| Mallory Morales | SVP Finance, CAO | 3. Februar 2026 A | 27.533 | 0 | 0 | $0 |
| Michael Bookman | CHIEF LEGAL OFFICER, SECRETARY | 3. Februar 2026 A | 4.870 | 0 | 0 | $0 |
| Igor Matushansky | Chief Medical Officer | 3. Februar 2026 A | · | 0 | 0 | $0 |
| Scott Barrett | CHIEF MEDICAL OFFICER | 15. Februar 2023 A | 7.563 | 0 | 0 | $0 |
| Peter Feinberg | Direktor | 11. Juni 2026 A | 135.441 | 2 | 0 | $137.025 |
| Laurie Keating | Direktor | 11. Juni 2026 A | 14.000 | 0 | 0 | $0 |
| Diana Hausman | Direktor | 11. Juni 2026 A | 3.000 | 0 | 0 | $0 |
| Thomas J. Schall | Direktor | 11. Juni 2026 A | 74.530 | 1 | 0 | $101.082 |
| CARPENTER ROBERT J | Direktor | 11. Juni 2026 A | 1.148.839 | 0 | 0 | $0 |
| Ann E Berman | Direktor | 13. Juni 2025 A | 67.465 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 12 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IWC · iShares Trust | 0,06% | 182.497 SH | 11. September 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 46.623 SH | 19. August 2026 | Täglich |
| IBB · iShares Trust | 0,02% | 433.352 SH | 11. September 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,02% | 4.578 SH | 2. Oktober 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 307.879 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,01% | 1.389.785 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 25.525 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 612.343 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.623.577 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4.583 SH | 19. August 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,00% | 3.598 NS | 31. Juli 2026 | N-PORT |
| IWN · iShares Trust | · | 493.615 SH | 11. September 2026 | Täglich |
IMRX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 13 Analysten
KAUF
Median-Ziel
$15.50
+280,8%
4 30,8%
Starker Kauf
8 61,5%
Kauf
1 7,7%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
6 Analysten · 2026-09-28Mittelwert-Ziel $17.17 +321,8%
← Unter allen Zielen
Aktueller Preis $4.07
Tief$12.00
Mittelwert$17.17
Hoch$30.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| IMRX | · | -5.2 | · | · | -45.3% | · |
| SABS | · | · | · | · | · | · |
| IPSC | $87M | -7.1 | 1556.8% | -8.8% | -5.2% | · |
| TLSI | · | · | · | · | · | · |
| ANIK | $133M | -12.6 | -5.9% | -9.6% | -7.5% | 56.6% |
| PALI | $375M | -7.8 | · | · | -25.4% | · |
| STRO | $99M | -0.5 | 65.2% | -186.5% | 232.2% | · |
| GLSI | $300M | -14.7 | · | · | -2159.7% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 5, 2026